Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition ; volume:50 ; number:9 ; day:22 ; month:4 ; year:2023 ; pages:2621-2635 ; date:7.2023
European journal of nuclear medicine and molecular imaging ; 50, Heft 9 (22.4.2023), 2621-2635, 7.2023
- Creator
-
Zboralski, Dirk
Osterkamp, Frank
Christensen, Esben
Bredenbeck, Anne
Schumann, Anne
Hoehne, Aileen
Schneider, Eberhard
Paschke, Matthias
Ungewiss, Jan
Haase, Christian
Robillard, Liliane
Simmons, Andrew D.
Harding, Thomas C.
Nguyen, Minh
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00259-023-06211-6
- URN
-
urn:nbn:de:101:1-2023093011120963280634
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Zboralski, Dirk
- Osterkamp, Frank
- Christensen, Esben
- Bredenbeck, Anne
- Schumann, Anne
- Hoehne, Aileen
- Schneider, Eberhard
- Paschke, Matthias
- Ungewiss, Jan
- Haase, Christian
- Robillard, Liliane
- Simmons, Andrew D.
- Harding, Thomas C.
- Nguyen, Minh
- SpringerLink (Online service)
Other Objects (12)
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control
Therapeutic Remodeling of the Tumor Microenvironment Enhances Nanoparticle Delivery
Tumor microenvironment reprogramming combined with immunogenic enhancement by nanoemulsions potentiates immunotherapy
Immune checkpoint modulation enhances oncolytic virotherapy
Tumor Microenvironment‐Triggered Aggregated Magnetic Nanoparticles for Reinforced Image‐Guided Immunogenic Chemotherapy
Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Fibroblast-associated tumour microenvironment induces vascular structure-networked tumouroid
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
Correction: Targeting of focal adhesion kinase enhances the immunogenic cell death of PEGylated liposome doxorubicin to optimize therapeutic responses of immune checkpoint blockade
Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Tumor microenvironment modulation enhances immunologic benefit of chemoradiotherapy
Targeted delivery of immunogenic antigen to the tumor microenvironment after irradiation facilitates tumor control